Plasma Protein Therapeutics Market is projected to expandat a CAGR Of 6.5% between 2023 and 2031. A variety of life-threatening & chronic disorders such as hematological diseases, immune deficiencies, genetic diseases, and neurological disorders among others are treated with plasma proteins. The different clinical responses of plasma proteins are due to its unique biochemical profile, and variances in production & processing technologies. Recent developments observed in the plasma protein therapeutics industry are satisfactory and groundbreaking, especially recently approved recombinant protein therapeutics which cater to several clinical indications such as autoimmune diseases, cancers, infectious diseases, and genetic disorders. These developments in plasma protein therapeutics technologies have allowed industry players to use the maximum potential of proteins in therapeutics by equivalently maintaining product safety and efficacy. The key factors driving this market are huge applications of immunoglobulins and albumin, catering a wide range of diseases, rising investment in research and development of novel plasma protein-based drugs, and increasing off-label use of immunoglobulins.
Global regulatory framework is evolving day by day with the incessant development of novel technologies in the biopharmaceutical industry. In the case of plasma protein therapeutics improved versions of current therapies are being introduced that are mainly attained through enhanced drug targeting and enhancement in functionality and potency. Thus, the plasma protein therapeutics market is expected to experience tremendous growth in the near future.
North America was observed as the largest plasma protein therapeutics market due rising prevalence of chronic diseases, high acceptance & accessibility towards novel drug therapy, and mounting investments in R&D of plasma proteins therapeutics. Asia Pacific was observed as the fastest-growing plasma protein therapeutics market due to rising demand for novel therapeutics, developing healthcare infrastructure, and rising prevalence of cancer and autoimmune diseases.
New plasma-derived therapies entering the market is on the rise which is the major factor assisting the overall market growth. On the other hand, major market restraints include stringent regulatory policies, evolving reimbursement policies for developing the plasma protein therapeutics industry, and intricacy in manufacturing.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends, and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
Global regulatory framework is evolving day by day with the incessant development of novel technologies in the biopharmaceutical industry. In the case of plasma protein therapeutics improved versions of current therapies are being introduced that are mainly attained through enhanced drug targeting and enhancement in functionality and potency. Thus, the plasma protein therapeutics market is expected to experience tremendous growth in the near future.
North America was observed as the largest plasma protein therapeutics market due rising prevalence of chronic diseases, high acceptance & accessibility towards novel drug therapy, and mounting investments in R&D of plasma proteins therapeutics. Asia Pacific was observed as the fastest-growing plasma protein therapeutics market due to rising demand for novel therapeutics, developing healthcare infrastructure, and rising prevalence of cancer and autoimmune diseases.
New plasma-derived therapies entering the market is on the rise which is the major factor assisting the overall market growth. On the other hand, major market restraints include stringent regulatory policies, evolving reimbursement policies for developing the plasma protein therapeutics industry, and intricacy in manufacturing.
Key players identified for plasma protein therapeutics market include:
Baxter International, Biotests, CSL Behring, GRIFOLS, S.A, Kedrion, Octapharma USA, Inc., Shire Plc., China Biologics, and Others.Historical & Forecast Period
This study report represents an analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends, and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. A key data point that enables the estimation of Plasma Protein Therapeutics market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price, and value.
- Geographical revenues generated by countries considered in the report
- Micro and macro environment factors that are currently influencing the Plasma Protein Therapeutics market and their expected impact during the forecast period.
Market Segmentation
Product
- Immunoglobulins
- Albumin
- Coagulation Factors
- Alpha-1 Proteinase Inhibitor
- Others (C1-esterase Inhibitors & Hyperimmune Globulins)
- Pipeline Analysis
- Phase III Drugs Analysis, Forecast till 2026
- Phase II & Phase I (Tabular Representation)
Application
- Hemophilia
- Primary Immunodeficiency Disorder
- Idiopathic Thrombocytopenic Purpura
- Secondary Immunodeficiency
- Others (Kawasaki Disease, Hereditary Angioedema, GBS, and CIDP)
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Plasma Protein Therapeutics market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Plasma Protein Therapeutics market?
- Which is the largest regional market for Plasma Protein Therapeutics market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Plasma Protein Therapeutics market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Plasma Protein Therapeutics market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Plasma Protein Therapeutics Market
2.2. Global Plasma Protein Therapeutics Market, By Product, 2022 (US$ Million)
2.3. Global Plasma Protein Therapeutics Market, By Application, 2022 (US$ Million)
2.4. Global Plasma Protein Therapeutics Market, By Geography, 2022 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2022
3. Plasma Protein Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Plasma Protein Therapeutics Market Vendors
3.2. Strategies Adopted by Plasma Protein Therapeutics Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Plasma Protein Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Plasma Protein Therapeutics Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Immunoglobulins
5.3.2. Albumin
5.3.3. Coagulation Factors
5.3.4. Alpha-1 Proteinase Inhibitor
5.3.5. Others (C1-esterase Inhibitors & Hyperimmune Globulins)
5.3.6. Pipeline Analysis
5.3.6.1. Phase III Drugs Analysis, Forecast till 2026
5.3.6.2. Phase II & Phase I (Tabular Representation)
6. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Hemophilia
6.3.2. Primary Immunodeficiency Disorder
6.3.3. Idiopathic Thrombocytopenic Purpura
6.3.4. Secondary Immunodeficiency
6.3.5. Others (Kawasaki Disease, Hereditary Angioedema, GBS, and CIDP)
7. North America Plasma Protein Therapeutics Market, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
7.3. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
7.4.Plasma Protein Therapeutics Market: By Region, 2021-2031, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
7.4.1.1.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
7.4.1.2.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
7.4.1.3.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
8. UK and European Union Plasma Protein Therapeutics Market, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
8.3. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
8.4.Plasma Protein Therapeutics Market: By Region, 2021-2031, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
8.4.1.1.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
8.4.1.2.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
8.4.1.3.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
8.4.1.4.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
8.4.1.5. France
8.4.1.5.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
8.4.1.5.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
8.4.1.6.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
9. Asia Pacific Plasma Protein Therapeutics Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
9.3. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
9.4.Plasma Protein Therapeutics Market: By Region, 2021-2031, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
9.4.1.1.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
9.4.1.2.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
9.4.1.3. India
9.4.1.3.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
9.4.1.3.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
9.4.1.4.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
9.4.1.5.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
9.4.1.6.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
10. Latin America Plasma Protein Therapeutics Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
10.3. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
10.4.Plasma Protein Therapeutics Market: By Region, 2021-2031, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
10.4.1.1.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
10.4.1.2.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
10.4.1.3.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
11. Middle East and Africa Plasma Protein Therapeutics Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
11.3. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
11.4.Plasma Protein Therapeutics Market: By Region, 2021-2031, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
11.4.1.1.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
11.4.1.2.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Plasma Protein Therapeutics Market: By Product, 2021-2031, USD (Million)
11.4.1.3.1. Plasma Protein Therapeutics Market: By Application, 2021-2031, USD (Million)
12. Company Profile
12.1. Baxter International
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Biotests
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. CSL Behring
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. GRIFOLS, S.A
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Kedrion
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Octapharma USA, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Shire Plc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. China Biologics
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Others
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
List of Figures
Figure 1 Global Plasma Protein Therapeutics Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Plasma Protein Therapeutics Market: Quality Assurance
Figure 5 Global Plasma Protein Therapeutics Market, By Product, 2022
Figure 6 Global Plasma Protein Therapeutics Market, By Application, 2022
Figure 7 Global Plasma Protein Therapeutics Market, By Geography, 2022
Figure 8 Market Geographical Opportunity Matrix - Global Plasma Protein Therapeutics Market, 2022
Figure 9 Market Positioning of Key Plasma Protein Therapeutics Market Players, 2022
Figure 10 Global Plasma Protein Therapeutics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure 11 Global Plasma Protein Therapeutics Market, By Product, 2022 Vs 2031, %
Figure 12 Global Plasma Protein Therapeutics Market, By Application, 2022 Vs 2031, %
Figure 13 U.S. Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 14 Canada Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 15 Rest of North America Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 16 UK Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 17 Germany Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 18 Spain Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 19 Italy Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 20 France Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 21 Rest of Europe Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 22 China Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 23 Japan Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 24 India Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 25 Australia Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 26 South Korea Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 27 Rest of Asia Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 28 Brazil Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 29 Mexico Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 30 Rest of Latin America Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 31 GCC Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 32 Africa Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
Figure 33 Rest of Middle East and Africa Plasma Protein Therapeutics Market (US$ Million), 2021 - 2031
List of Figures
Table 1 Global Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 2 Global Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 3 Global Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 4 North America Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 5 North America Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 6 North America Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 7 U.S. Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 8 U.S. Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 9 U.S. Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 10 Canada Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 11 Canada Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 12 Canada Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 13 Rest of North America Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 14 Rest of North America Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 15 Rest of North America Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 16 UK and European Union Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 17 UK and European Union Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 18 UK and European Union Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 19 UK Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 20 UK Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 21 UK Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 22 Germany Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 23 Germany Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 24 Germany Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 25 Spain Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 26 Spain Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 27 Spain Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 28 Italy Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 29 Italy Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 30 Italy Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 31 France Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 32 France Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 33 France Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 34 Rest of Europe Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 35 Rest of Europe Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 36 Rest of Europe Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 37 Asia Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 38 Asia Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 39 Asia Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 40 China Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 41 China Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 42 China Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 43 Japan Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 44 Japan Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 45 Japan Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 46 India Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 47 India Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 48 India Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 49 Australia Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 50 Australia Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 51 Australia Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 52 South Korea Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 53 South Korea Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 54 South Korea Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 55 Latin America Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 56 Latin America Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 57 Latin America Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 58 Brazil Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 59 Brazil Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 60 Brazil Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 61 Mexico Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 62 Mexico Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 63 Mexico Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 64 Rest of Latin America Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 65 Rest of Latin America Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 66 Rest of Latin America Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 67 Middle East and Africa Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 68 Middle East and Africa Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 69 Middle East and Africa Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 70 GCC Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 71 GCC Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 72 GCC Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 73 Africa Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 74 Africa Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 75 Africa Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Table 76 Rest of Middle East and Africa Plasma Protein Therapeutics Market By Product, 2021-2031, USD (Million)
Table 77 Rest of Middle East and Africa Plasma Protein Therapeutics Market By Pipeline Analysis, 2021-2031, USD (Million)
Table 78 Rest of Middle East and Africa Plasma Protein Therapeutics Market By Application, 2021-2031, USD (Million)
Companies Mentioned
- Baxter International
- Biotests
- CSL Behring
- GRIFOLS S.A
- Kedrion
- Octapharma USA Inc.
- Shire Plc.
- China Biologics
